Companies: 10,795·Total market cap: $144.5T
ImageneBio Inc

ImageneBio Inc

IMANASDAQHealthcare● Active
$5.52
$-0.11(-1.95%)
Market Cap$62260798
P/E Ratio—
52W High$18
52W Low$3.94
Overview

ImageneBio Inc (IMA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001835579 · IMA · NASDAQ · as of Jun 9, 2026

Filing snapshot

310
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
1998
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001835579 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-10
Fiscal Year End
Mar 10, 2026
Accession No.
0001193125-26-099434
Primary Document
ima-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001835579 · Accession 0001193125-26-099434

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
424B3424B3
424B3
2026-05-08
View
424B3424B3
424B3
2026-05-07
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
ARSARS
ARS
2026-04-30
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-30
View
DEF 14AProxy Statement
DEF 14A
2026-04-30
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-29
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-21
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-04-21
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-20
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-16
View
424B3424B3
424B3
2026-04-13
View
Showing 1–15 of 228 filingsForm 4 / 144 hidden· 310 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001835579  |  Exchange: NASDAQ · Healthcare

ImageneBio Inc (NASDAQ: IMA) has submitted 310 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1998. As a Healthcare sector company with CIK 0001835579, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is ImageneBio Inc's most comprehensive regulatory disclosure. The most recent ImageneBio Inc 10-K was filed on 2026-03-10 for fiscal year ending 2026. Historical IMA 10-K annual reports are available from 2021 through 2026.

Investors researching ImageneBio Inc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
OVID SEC Filings →STRO SEC Filings →STTK SEC Filings →ARTV SEC Filings →CNTX SEC Filings →CNTB SEC Filings →IFRX SEC Filings →KLRS SEC Filings →
→ IMA Financials→ IMA Earnings→ IMA Insider Trades

Frequently Asked Questions

IMA SEC Filings · 8 questions

ImageneBio Inc (IMA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 310 filings and access original documents at no cost. ImageneBio Inc's CIK is 0001835579.

IMA SEC filingsImageneBio Inc SEC documentsfind IMA 10-K